JP2024518413A5 - - Google Patents
Info
- Publication number
- JP2024518413A5 JP2024518413A5 JP2023568340A JP2023568340A JP2024518413A5 JP 2024518413 A5 JP2024518413 A5 JP 2024518413A5 JP 2023568340 A JP2023568340 A JP 2023568340A JP 2023568340 A JP2023568340 A JP 2023568340A JP 2024518413 A5 JP2024518413 A5 JP 2024518413A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- nls
- sequence
- polypeptide
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163185315P | 2021-05-06 | 2021-05-06 | |
| US63/185,315 | 2021-05-06 | ||
| US202263315483P | 2022-03-01 | 2022-03-01 | |
| US63/315,483 | 2022-03-01 | ||
| PCT/US2022/028208 WO2022236147A1 (en) | 2021-05-06 | 2022-05-06 | Modified nucleases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518413A JP2024518413A (ja) | 2024-05-01 |
| JP2024518413A5 true JP2024518413A5 (cg-RX-API-DMAC7.html) | 2025-05-13 |
Family
ID=81975392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568340A Pending JP2024518413A (ja) | 2021-05-06 | 2022-05-06 | 修飾ヌクレアーゼ |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20260009009A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024518413A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3218053A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022236147A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023122762A1 (en) | 2021-12-22 | 2023-06-29 | Camp4 Therapeutics Corporation | Modulation of gene transcription using antisense oligonucleotides targeting regulatory rnas |
| JP2026523341A (ja) | 2023-05-15 | 2026-07-14 | エヌクロマ・バイオ,インコーポレーテッド | Hbv遺伝子発現のエピジェネティック調節のための組成物および方法 |
| WO2026046724A1 (en) * | 2024-08-30 | 2026-03-05 | Cellectis Sa | Tale protein scaffolds involving fusions of monopartite and bipartite nls |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| EP3390624A4 (en) * | 2015-12-18 | 2019-07-10 | The Regents of The University of California | Modified site-directed modifying polypeptides and methods of use thereof |
| US9896696B2 (en) | 2016-02-15 | 2018-02-20 | Benson Hill Biosystems, Inc. | Compositions and methods for modifying genomes |
| US9982279B1 (en) | 2017-06-23 | 2018-05-29 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| CN111511906A (zh) * | 2017-06-23 | 2020-08-07 | 因思科瑞普特公司 | 核酸引导性核酸酶 |
| US10011849B1 (en) * | 2017-06-23 | 2018-07-03 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| WO2019051097A1 (en) * | 2017-09-08 | 2019-03-14 | The Regents Of The University Of California | RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USING SAME |
| AU2018383712B2 (en) * | 2017-12-11 | 2025-09-04 | Editas Medicine, Inc. | Cpf1-related methods and compositions for gene editing |
| EP3821008A1 (en) * | 2018-07-12 | 2021-05-19 | Keygene N.V. | Type v crispr/nuclease-system for genome editing in plant cells |
| WO2020086475A1 (en) * | 2018-10-22 | 2020-04-30 | Inscripta, Inc. | Engineered enzymes |
| WO2020092057A1 (en) * | 2018-10-30 | 2020-05-07 | Yale University | Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells |
| EP3874051A1 (en) * | 2018-10-31 | 2021-09-08 | Novozymes A/S | Genome editing by guided endonuclease and single-stranded oligonucleotide |
| CN113166798B (zh) * | 2018-11-28 | 2025-05-02 | 主基因有限公司 | 通过核酸内切酶保护的靶向富集 |
| CA3140297A1 (en) * | 2019-06-19 | 2020-12-24 | Simon Auslaender | Method for the generation of a protein expressing cell by targeted integration using cre mrna |
| US12551560B2 (en) * | 2019-09-09 | 2026-02-17 | Scribe Therapeutics Inc. | Compositions and methods for use in immunotherapy |
| JP7689949B2 (ja) * | 2019-10-03 | 2025-06-09 | アーティサン ディベロップメント ラブズ インコーポレイテッド | 操作されたデュアルガイド核酸を有するcrisprシステム |
| EP4045651A1 (en) * | 2019-10-14 | 2022-08-24 | KWS SAAT SE & Co. KGaA | Mad7 nuclease in plants and expanding its pam recognition capability |
| AU2021216418A1 (en) | 2020-02-05 | 2022-09-01 | Danmarks Tekniske Universitet | Compositions and methods for targeting, editing or modifying human genes |
-
2022
- 2022-05-06 US US18/289,723 patent/US20260009009A1/en active Pending
- 2022-05-06 JP JP2023568340A patent/JP2024518413A/ja active Pending
- 2022-05-06 WO PCT/US2022/028208 patent/WO2022236147A1/en not_active Ceased
- 2022-05-06 CA CA3218053A patent/CA3218053A1/en active Pending
-
2023
- 2023-04-28 US US18/141,363 patent/US20230340437A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022271376B9 (en) | CRISPR/CAS-related methods and compositions for treating herpes simplex virus | |
| KR101817482B1 (ko) | 캄필로박터 제주니 crispr/cas 시스템 유래 rgen을 이용한 유전체 교정 | |
| Weiss et al. | RNA recognition by arginine‐rich peptide motifs | |
| Scott et al. | Purification of the rep protein of Escherichia coli. An ATPase which separates duplex DNA strands in advance of replication. | |
| JP2023516226A5 (cg-RX-API-DMAC7.html) | ||
| Petty et al. | Infectious barley stripe mosaic virus RNA transcribed in vitro from full-length genomic cDNA clones | |
| JP2022545385A5 (cg-RX-API-DMAC7.html) | ||
| Van der Ploeg et al. | Antigenic variation in African trypanosomes | |
| JP2024535672A5 (cg-RX-API-DMAC7.html) | ||
| JP2022519882A5 (cg-RX-API-DMAC7.html) | ||
| HEYDEN et al. | Single RNA polymerase binding site isolated | |
| CN106191071A (zh) | 一种CRISPR‑Cas9系统及其用于治疗乳腺癌疾病的应用 | |
| JP2025073123A5 (cg-RX-API-DMAC7.html) | ||
| CN114144519B (zh) | 单碱基置换蛋白以及包含其的组合物 | |
| Bhat et al. | Complete nucleotide sequence of a cDNA derived from calf lens γ-crystallin mRNA: presence of Alu I-like DNA sequences | |
| CA2365984A1 (en) | Antisense oligonucleotides comprising universal and/or degenerate bases | |
| Cerritelli et al. | Cloning, expression, and mapping of ribonucleases H of human and mouse related to bacterial RNase HI | |
| JP2024511131A5 (cg-RX-API-DMAC7.html) | ||
| JP2022513459A5 (cg-RX-API-DMAC7.html) | ||
| Chen et al. | Amino acids essential for RNase H activity of hepadnaviruses are also required for efficient elongation of minus-strand viral DNA | |
| CA2088154A1 (en) | Portable ribozyme cassettes, dna sequences containing them, ribozyme encoded by these dna sequences, and compositions containing these ribozymes | |
| Bautz | Requlation of RNA Synthesis | |
| CN110331147A (zh) | 一种mRNA的制备方法及其在肿瘤治疗中的应用 | |
| US20200224194A1 (en) | Expression systems that facilitate nucleic acid delivery and methods of use | |
| KR20180128864A (ko) | 매칭된 5' 뉴클레오타이드를 포함하는 가이드 rna를 포함하는 유전자 교정용 조성물 및 이를 이용한 유전자 교정 방법 |